More stories

  • in

    Why the global soil shortage threatens food, medicine and the climate

    Soil can be considered black gold, and we’re running out it.
    The United Nations declared soil finite and predicted catastrophic loss within 60 years.

    “There are places that have already lost all of their topsoil,” Jo Handelsman, author of “A World Without Soil,” and a professor at the University of Wisconsin-Madison, told CNBC.
    The impact of soil degradation could total $23 trillion in losses of food, ecosystem services and income worldwide by 2050, according to the United Nations Convention to Combat Desertification.
    “We have identified 10 soil threats in our global report … Soil erosion is number one because it’s taking place everywhere,” Ronald Vargas, the secretary of the Global Soil Partnership and Land and Water Officer at the Food and Agriculture Organization of the United Nations, told CNBC.
    According to the U.N., soil erosion may reduce up to 10% of crop yields by 2050, which is the equivalent of removing millions of acres of farmland.
    And when the world loses soil, food supply, clean drinking water and biodiversity are threatened.

    What’s more, soil plays an important role in mitigating climate change.
    Soil contains more than three times the amount of carbon in the earth’s atmosphere and four times as much in all living plants and animals combined, according to the Columbia Climate School.
     “Soil is the habitat for over a quarter of the planet’s biodiversity. Each gram of soil contains millions of cells of bacteria and fungi that play a very important role in all ecosystem services,” Reza Afshar, chief scientist at the regenerative agriculture research farm at the Rodale Institute, told CNBC.
    The Rodale Institute in Kutztown, Pennsylvania, is known as the birthplace of modern organic agriculture. 
    “The projects we do here are centered around improving and rebuilding soil health. We have a farming system trial that’s been running for 42 years,” Afshar said. It is the longest-running side-by-side comparison of organic and conventional grain cropping systems in North America.
    The research has found regenerative, organic agriculture produces yields up to 40% higher during droughts, can earn farmers greater profits and releases 40% fewer carbon emissions than conventional agricultural practices.
    How’s that possible? The Rodale Institute says it all starts with the soil.
    “When we talk about healthy soil, we are talking about all aspects of the soil, chemical, physical and biological that should be in a perfect status to be able to produce healthy food for us,” Afshar said.
    It’s critical, of course, because the world relies on soil for 95% of our food production. But that’s just the beginning of its importance.
    “The good news is that we know enough to get to work,” Dianna Bagnall, a research soil scientist at the Soil Health Institute, told CNBC.
    Watch the video above to learn more about why we’re facing a silent soil crisis, how soil can be saved and what that means for the world.

    WATCH LIVEWATCH IN THE APP More

  • in

    Union claims Starbucks illegally closing cafe to retaliate, Bloomberg reports

    The workers union at Starbucks is claiming the coffee chain is shutting down a recently unionized cafe in retaliation for its activist efforts, Bloomberg News reported.
    It’s the latest escalation between a rapidly growing national labor movement and the coffee giant.
    Workers United reportedly said in a Friday filing with the National Labor Relations Board that Starbucks is violating federal labor law by permanently closing an Ithaca, New York, store.

    A pro-union poster is seen on a lamp pole outside Starbucks’ Broadway and Denny location in Seattle’s Seattle’s Capitol Hill neighborhood on March 22, 2022.
    Toby Scott | Sopa Images | Lightrocket | Getty Images

    The workers union at Starbucks is claiming the coffee chain is shutting down a recently unionized cafe in retaliation for its activist efforts.
    It’s the latest escalation between a rapidly growing national labor movement and the coffee giant.

    Workers United, the union that’s backing organizing efforts at Starbucks, said in a Friday filing with the National Labor Relations Board that Starbucks is violating federal labor law by permanently closing an Ithaca, New York, store. The group alleged it was in retaliation since employees at the location voted to unionize in April.
    The Ithica store employees say they originally went on strike for unsafe working conditions on Apr. 16. Workers walked out due to a waste emergency caused by the overflowing grease trap, according to the union’s statement. In an email to the union’s bargaining committee, Starbucks cited the grease trap as the reason for the store closure.
    The union committee alleges that Starbucks closed the store in retaliation for activity protected by federal labor law and to stop workers elsewhere from organizing. “It is a clear attempt to scare workers across the country by retaliating against its own employees,” the committee said in a statement.
    Starbucks said that it opens and closes stores “as a regular part” of its operations. “Our goal is to ensure that every partner is supported in their individual situation, and we have immediate opportunities available in the market,” a Starbucks spokesperson said in an email to CNBC.
    The union is asking the agency to seek a federal court injunction to quickly prevent or reverse the store closure.

    Around 100 Starbucks cafes have voted to unionize under Workers United, while only 14 locations have voted against unionizing. Workers United announced this week it was creating a $1 million fund to cover lost pay for baristas who go on strike.
    Workers United has filed at least 175 complaints against the coffee chain for unfair labor practices, CNBC previously reported. Starbucks has denied wrongdoing.
    The worker union claims were first reported by Bloomberg News.
    — CNBC’s Amelia Lucas contributed to this report.

    WATCH LIVEWATCH IN THE APP More

  • in

    Abbott Nutrition restarts baby formula production in reopened Michigan plant

    Abbott Nutrition has resumed baby formula production at its Sturgis, Michigan, plant, in a move to address a nationwide shortage.
    The company said it will restart the production of EleCare, a formula for children with digestive issues, aiming for an initial product release around June 20.

    Shelves normally meant for baby formula sit nearly empty at a store in downtown Washington, DC, on May 22, 2022.
    Samuel Corum | AFP | Getty Images

    Abbott Nutrition on Saturday resumed baby formula production at its Sturgis, Michigan, plant, a move toward addressing a nationwide shortage.The company has been given the green light from the U.S. Food and Drug Administration after meeting “initial requirements” as part of a May 16 consent decree.
    The company said it will restart the production of EleCare, a formula for children who struggle to digest other products, along with other specialty and metabolic formulas.

    Abbott aims for an initial EleCare product release around June 20 and is working to meet guidelines to resume production of Similac and other formulas.
    “We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America,” a spokesperson for Abbott said in a statement. “We will ramp production as quickly as we can while meeting all requirements.”While supply problems started early in the Covid-19 pandemic, issues worsened in part due to the February closure of the Michigan plant amid scrutiny over contamination.
    FDA investigations began after four infants were hospitalized with bacterial infections from drinking its powdered formula. Two of the babies died.
    “The FDA is continuing to work diligently to ensure the safe resumption of production of infant formula at Abbott Nutrition’s Sturgis, Michigan, facility,” the FDA said in a statement.
    “The agency expects that the measures and steps it is taking, and the potential for Abbott Nutrition’s Sturgis, Michigan, facility, to safely resume production in the near-term, will mean more and more infant formula is either on the way to or already on store shelves moving forward,” the FDA said.  
    Abbott Nutrition is the largest baby formula manufacturer in the U.S.

    WATCH LIVEWATCH IN THE APP More

  • in

    The CDC is sending monkeypox vaccines to people at high risk in a race to prevent the spread

    The U.S. has distributed 1,200 doses of vaccine across the U.S. for people who have had high risk exposures to monkeypox.
    The U.S. has two vaccines in its national stockpile that can be used against monkeypox.
    Jynneos is a newer generation two-dose vaccine approved to prevent monkeypox, while ACAM2000 is an older generation smallpox vaccine that can have serious side effects.
    Most people who catch monkeypox generally recover in two to four weeks without specific medical treatment.

    Test tubes labelled “Monkeypox virus positive and negative” are seen in this illustration taken May 23, 2022. 
    Dado Ruvic | Reuters

    The Biden administration has distributed 1,200 monkeypox vaccine doses for people who have had high-risk exposures to the virus, part of a nationwide public health response to stamp out the disease before it causes a major outbreak.
    U.S. health officials, worried the virus is spreading faster than previously thought, have said the global outbreak of monkeypox is the largest ever. The World Health Organization said Wednesday that there are now more than 550 cases across 30 countries. In the U.S., at least 20 confirmed or suspected cases have been reported in 11 states, including California, Colorado, Florida, Georgia, Illinois, Massachusetts, New York, Pennsylvania, Virginia, Utah and Washington state, according to the Centers for Disease Control and Prevention.

    “A monkeypox outbreak of this scale and scope across the world, it has not been seen before,” Dr. Raj Panjabi, who leads the White House pandemic preparedness office, told reporters on a call last week.
    However, CDC officials have sought to reassure the public that the arrival of monkeypox in the U.S. is vastly different from Covid-19, which blindsided the country two years ago. Scientists knew little about Covid when it first emerged and the U.S. had no vaccines or antiviral treatments to fight the virus in 2020.
    Monkeypox, on the other hand, has been known to scientists since 1958 when the virus was first identified during outbreaks among monkeys kept for research purposes, and its transmission in humans has been studied since the 1970s. Global health authorities also have extensive experience successfully fighting smallpox, which the World Health Organization declared eradicated in 1980 after a successful global vaccination effort. Monkeypox is in the same virus family as smallpox though it is much milder.

    Stockpiling vaccine

    CDC Director Dr. Rochelle Walensky told reporters last week that the U.S. has been preparing for an outbreak from a virus like monkeypox for decades. The U.S. has millions of vaccine doses in the strategic national stockpile that protect against monkeypox and smallpox as well as antiviral pills to treat the diseases.
    Dawn O’Connell, who leads the Health and Human Services office responsible for the strategic national stockpile, said on Friday that the U.S. has enough vaccine on hand to manage the current monkeypox outbreak. However, O’Connell would not disclose how many shots the U.S. has at the ready.

    The U.S. has two vaccines but the preferred option is in shorter supply. Jynneos is a two-dose vaccine approved by the FDA in 2019 to prevent monkeypox in people ages 18 and older. The CDC generally recommends Jynneos over the other option, ACAM2000, which is an older generation smallpox vaccine that can have serious side effects. 
    Last week, CDC official Dr. Jennifer McQuiston said the U.S. has 1,000 doses of Jynneos available. However, the Danish biotech company that makes the shots, Bavarian Nordic, said the U.S. actually has a supply of more than 1 million Jynneos frozen doses stored in the U.S. and Denmark under an order placed in April 2020. The shots have a shelf life of three years.
    The U.S. has ordered close to 30 million Jynneos doses since 2010 but 28 million of them expired, the spokesperson said. Bavarian Nordic plans to increase production this summer and has the capacity to produce 30 million shots a year, the spokesperson said.

    The U.S. government also has a stockpile of more than 100 million doses of ACAM2000, made by Emergent BioSolutions, McQuiston told reporters last week. The U.S. had released 500 doses of Jynneos and 200 doses of ACAM2000 as of Tuesday, according to the CDC. The U.S. has also sent out 100 courses of the oral antiviral tecovirimat to the states, health officials said Friday.
    “We want to ensure that people with high risk exposures have rapid access to vaccines and if they become sick, can receive appropriate treatment,” Panjabi said on a call with reporters Friday. Jynneos and ACAM2000 can be administered before or after exposure to the virus. However, patients need to receive the vaccines within 4 days of exposure to prevent disease onset.
    ACAM2000 has demonstrated high levels of protection against monkeypox in animal models and is expected to provide 85% protection against disease from the virus similar to earlier versions of smallpox vaccines, according to Mike Slifka, an immunologist at Oregon Health and Science University who has studied monkeypox. Less is known about Jynneos because the vaccine is newer but it produced reasonable antibody levels in humans and should protect against severe disease, Slifka said.

    Side effects

    The CDC generally recommends Jynneos over ACAM2000 because it is considered safer. ACAM2000 can have serious side effects, and distributing the vaccine widely would require serious discussion, McQuiston said in a call with reporters last week. ACAM2000 uses a mild virus strain in the same family as monkeypox and smallpox that can still replicate, which means there’s a risk that the live virus in the vaccine can spread in the human body or to other people.
    ACAM2000 is administered with a two-pronged needle that is scratched into the upper arm and the virus then grows into a localized infection in the form of a blister. The patient can potentially spread the virus to other people, or to other parts of their body if they scratch the blister and then rub their eye for example, which can result in vision damage. The FDA warns that it’s very important for people vaccinated with ACAM2000 to take proper care of the vaccination site so they don’t spread the virus to other people or other parts of the body.

    CDC warning

    The CDC has said women who are pregnant or breast feeding, people with weak immune systems, those with skin conditions such as eczema or atopic dermatitis, and people with heart disease should not receive ACAM2000. In pregnant women, the virus can spread to the fetus and cause stillbirth. People with weak immune systems face a risk that the virus will grow uncontrollably and cause a dangerous infection, Slifka said. People with skin conditions such as eczema or atopic dermatitis are also at risk of the virus spreading on their skin which can turn into a life-threatening infection, he said.

    The Jynneos vaccine, on the other hand, is not associated with these risks because it uses a virus strain that is no longer able to replicate in humans, according to Slifka. It is also administered with a normal syringe like other common shots such as the flu vaccine.
    Given the potential side effects of ACAM2000, the vaccine would likely only see wide use in the context of a major smallpox epidemic because that virus is so deadly, according to Dr. Peter Hotez, an infectious disease and vaccine expert at Baylor College of Medicine in Texas. Monkeypox, on the other hand, is a much milder virus and no deaths have been reported in the recent cases in Europe and North America.

    Mortality rate

    Smallpox can have a fatality rate as high as 30%, according to the WHO. The West African strain of monkeypox that appears to be driving the current outbreak likely has a mortality rate somewhere around 1%, though data is sparse because the virus has previously spread mostly in remote parts Africa. Most people recover within two to four weeks without specific medical treatment, according to the CDC. There’s another monkeypox strain, Congo Basin, associated with a higher death rate of 3% to 10%, according to the WHO.
    “We’re very lucky that the outbreak right is the low virulence West African strain,” said Dr. Rachel Roper, a professor of microbiology and immunology at East Carolina University who has studied monkeypox.
    Though the U.S. has far more tools and more knowledge to fight monkeypox than it had against Covid in 2020, there are still many unknowns about the current outbreak. It’s unclear why the virus is now spreading in countries outside West and Central Africa where virus is endemic. Historically, the virus spread in small villages in Africa by jumping from rodents that carry the virus to humans with very little transmission between people, Slifka said. However, the virus now appears to be spreading better between people, he said.
    “Through intimate contact and skin-to-skin transmission, it’s transmitting better than it has under other circumstances,” Slifka said.
    Most monkeypox patients in the U.S. travelled internationally in the 21 days before symptom onset which suggests they picked up the virus outside the country, according to McQuiston. The CDC doesn’t believe monkeypox is spreading widely in the U.S right now but is closely monitoring the situation. The U.S. has conducted 120 tests so far for orthopoxvirus, the family that includes monkeypox.

    Community transmission

    “There could be community level transmission that is happening, and that’s why we want to really increase our surveillance efforts,” McQuiston told reporters during a call on Friday. “We want to really encourage physicians that if they see a rash and they’re concerned it might be monkeypox to go ahead and test for that,” she said.

    WHO officials said on Wednesday that the sudden appearance of monkeypox in multiple countries in North America and Europe indicates that the virus has probably been spreading outside West and Central Africa undetected for some time, though it is unclear for how long. Dr. Rosamund Lewis, the WHO’s technical lead for monkeypox, said the virus may be spreading more now because immunity in the human population has waned since smallpox vaccination was halted after the disease was eradicated.
    Lewis said the WHO is not recommending mass vaccination against monkeypox because the current outbreak can still be contained. Most of the cases so far have been reported among men who have sex with men, developed symptoms and sought care at sexual health clinics, according to the WHO. Lewis said it is important to provide gay and bisexual men with the information they need to protect themselves from the virus and prevent it from spreading.

    Symptoms

    The CDC has told people with confirmed or suspected monkeypox infections to isolate at home until local or state health departments say otherwise. People with confirmed infections should remain in isolation until the skin lesions that characterize the disease have completely resolved, the scabs have fallen off and a new layer of skin has formed.
    Monkeypox typically starts with symptoms similar to the flu including fever, headache, muscle aches, chills, exhaustion and swollen lymph nodes. Lesions then form on the body, and the virus spreads primarily through skin-to-skin contact with these lesions. Monkeypox can spread through respiratory droplets if a person has lesions in their throat or mouth, but it does not transmit easily this way.
    People exposed to monkeypox should monitor for symptoms for 21 days, according to the CDC. They should check their temperature twice daily and monitor for chills, swollen lymph nodes and new skin rashes. If a fever or rash develops, the person should self isolate and contact the local health department immediately.

    WATCH LIVEWATCH IN THE APP More

  • in

    Red Bull, Ferrari and Mercedes say 'no way' of staying below budget cap as they fear F1 penalties

    Max Verstappen of the Netherlands driving the (1) Oracle Red Bull Racing RB18 leads Charles Leclerc of Monaco driving the (16) Ferrari F1-75 during the F1 Monaco GP on May 29, 2022 in Monte-Carlo, Monaco.
    Clive Mason | Formula 1 | Getty Images

    Formula 1’s top teams Red Bull, Ferrari and Mercedes all believe they are at risk of penalties for going over the sport’s budget cap this season, with Christian Horner calling for the FIA to act quickly to avoid an “accounting world championship.”
    All F1 teams have a cost cap of $140 million (£119 million) for 2022 — with the limit intended to improve competition — but a dramatic rise in inflation and freight costs has put teams’ budgets under unexpected strains.

    That has led to Red Bull, Ferrari and Mercedes, the sport’s biggest and currently most competitive teams, all stressing that the budget cap to be increased due to the “force majeure” circumstances.
    However, there is opposition on the grid — such as from Alfa Romeo and Alpine, who see no reason to up the cap.
    “At the time we all agreed to those reductions, nobody could have predicted what was going on in the world and how that is driving inflation in every household globally,” Red Bull team principal Horner told Sky Sports F1.
    “We’re seeing it in Formula 1, we’re seeing it with logistics, we’re seeing it with energy costs. That to me is something the FIA need to take into account.
    “They have the ability through force majeure to apply an inflationary effect because we don’t have enough levers to get down to the cap. I think that’s the same for probably seven of the teams in Formula 1.

    “We’ve still got six months left this year, inflation still looks like it’s rising rather than diminishing, and hopefully the FIA will act shortly.”

    Read more from Sky Sports

    Agreeing with his rival team boss, Ferrari’s Mattia Binotto added: “I think that there will be no way for us to stay below. So, I’m pretty sure that at some stage we will go over.
    “In the regulations, there is a threshold, which is a 5%. If you do not exceed the 5% on the top of what’s the budget cap threshold, it will be considered a minor breach. And what’s a minor breach in case of force majeure? What will the stewards and the FIA decide on that, in terms of penalties?
    “No idea — but I don’t think there is any way for us — and for many teams — simply to stay within, and even laying-off people, I don’t think that’s a good and right choice.”
    Horner also stressed that Red Bull “were going to end up with more people in our financial department than we have in the drawing office” and added: “What we don’t want to see is that Formula 1 becomes an accounting world championship, rather than a technical or sporting one.”
    Mercedes are also siding with their rivals on the grid.
    “The cost cap was introduced for specific purposes, to allow the small teams to spend the same amount as the big ones,” explained Toto Wolff. “There shouldn’t be a bargaining every year to lift the cost cap up.
    “But I think we’re facing an exceptional situation in that we have a real inflation that is north of 7% at the moment. Our energy prices in Brackley have tripled, our freight costs have tripled.

    “I think that is something that needs to be considered because we want to avoid any circumstance, reorganizing restructuring the big teams again in a way that would be really damaging for us as a team and as an industry.
    “This is a force majeure situation, having a raging war in the Ukraine and the consequences that it had on energy prices is not something anybody could have foreseen.
    “There needs to be some sort of compromise for the teams that are against an inflationary adjustment and the teams that are for it.”
    ‘This is not a case of force majeure’ | Why other teams disagree
    Two of the teams that are against an adjustment are Alpine and Alfa Romeo.
    “Most teams do their budgets in November, December timeframe, for the following year and we are no different,” stressed Alpine’s Otmar Szafnauer. “And at that time, inflation was already at 7%+. RPI in England was 7.1%, 7.2%.
    “We took that into consideration when we did our budgets and laid out all the development work that we were going to do. And we’re still within it.
    “Where there’s a will there’s a way and we set a budget cap and we should stick to it.”

    Alfa Romeo’s Fred Vasseur, meanwhile, said that teams can just stop developing their cars sooner, reducing costs.
    “We are in this situation and sooner or later we will have to stop the development of the car because we will be at the limit of our budget. And I think everybody can do the same.
    “It’s absolutely not a case of force majeure, because inflation is not a case of force majeure.”
    Horner, however, said wanting the budget increased was “not about new parts.”
    “We haven’t introduced that many components, particularly compared to a standard season,” he continued. “Of course what we’re trying to do is be very selective in the parts that we’re producing.
    “It’s a very very different tactic and a very different way.
    “I think what we do need is clarity, and clarity quickly. Because, quite simply, it’s not right to be held to ransom by a couple of teams that aren’t perhaps effective — because that was never the design of the budget cap.
    “The budget cap was there to limit the top teams from a spending frenzy.”

    WATCH LIVEWATCH IN THE APP More

  • in

    Cramer's lightning round: I like Lam Research over Taiwan Semiconductor

    Monday – Friday, 6:00 – 7:00 PM ET

    It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

    Loading chart…

    Loading chart…

    Loading chart…

    Loading chart…

    Loading chart…

    Loading chart…

    Loading chart…

    Monolithic Power Systems Inc: “It sells at 40 times earnings, and you know I’m not recommending stocks unless they have a reasonable multiple.”

    Disclosure: Cramer’s Charitable Trust owns shares of Chevron.

    WATCH LIVEWATCH IN THE APP More

  • in

    U.S. monkeypox cases have more than doubled over the last week to 20, CDC says

    Dr. Jennifer McQuiston, a CDC official, said the overall health risk to the public remains low right now.
    Most of the U.S. patients had a history of international travel and it’s likely that they caught the virus while abroad, but it could be spreading domestically, McQuiston said.
    The majority of the patients so far self-identify as men who have sex with men. The CDC said it is working with the LGBTQ community to raise awareness about the virus.

    The World Health Organization has said that there is a “window” of opportunity to contain a recent monkeypox outbreak which has seen cases spread across Europe, the U.S. and Australia.
    Nurphoto | Nurphoto | Getty Images

    The U.S. has identified 20 confirmed or suspected monkeypox cases across 11 states as public health authorities increase testing in an effort to isolate patients and prevent the virus from spreading in communities, according to the Centers for Disease Control and Prevention.
    CDC official Dr. Jennifer McQuiston said the overall health risk to the public remains low right now. Most of the U.S. patients had a history of international travel and it’s likely that they caught the virus while abroad, but it could be spreading domestically.

    “There could be community-level transmission that is happening, and that’s why we want to really increase our surveillance efforts,” McQuiston told reporters during a call on Friday. “We want to really encourage physicians that if they see a rash and they’re concerned it might be monkeypox to go ahead and test for that,” she said.
    There does appear to be a higher risk for gay and bisexual men in these early cases. Of the 17 patients that have provided detailed demographic information to the CDC, 16 self-identified as men who have had sex with men, McQuiston said. Anyone can catch monkeypox through close physical contact and the CDC is closely monitoring for cases across all groups in the U.S. However, public health authorities are working to raise awareness in the LGBTQ community, McQuiston said.
    “Our priority is to help everyone make informed decisions to protect their health and the health of their community guided by science,” she said.

    There have been no reported deaths from monkeypox during the current outbreak in the U.S. or Europe, McQuiston said, adding that all patients are either in recovery or have already recovered.
    The West African strain of monkeypox is behind the current outbreak, which is less severe than the other strain known as Congo Basin, according to the CDC.

    Fourteen of the 17 patients who provided demographic data had a history of international travel to 11 different countries during the 21 days prior to symptom onset, according to the agency. The other three patients likely had contact with people who were infected.
    The current monkeypox outbreaks are unusual because they are occurring in countries in North America and Europe where the virus is not typically found. Monkeypox infections normally occur in remote areas of West and Central Africa, where it often spreads from rodents to people.
    The World Health Organization has identified more than 550 monkeypox infections across 30 countries, with most of the cases reported in Europe. The sudden appearance of these cases in multiple countries indicates the virus has been spreading undetected for some time outside the African regions, said WHO Director-General Tedros Adhanom Ghebreyesus during a press conference in Geneva on Wednesday.
    Some monkeypox cases in the U.S. may have gone undetected, McQuiston said, but the CDC doesn’t believe the virus has been circulating widely domestically.
    Dr. Raj Panjabi, who leads the White House pandemic preparedness office, said the U.S. is ramping up testing and contact tracing to contain the spread of the virus. Labs have performed 120 tests so far for orthopoxvirus, which includes monkeypox, Panjabi said. The U.S. has the capacity to conduct 1,000 tests daily across 67 labs in 46 states if necessary, he said.
    The Biden administration has also distributed 1,200 vaccine doses for people who have had high risk exposures to the virus and 100 oral antiviral treatment courses to people who are infected, Panjabi said. The U.S. has two vaccines, Jynneos and ACAM200, as well as an antiviral called tecovirimat in the national stockpile.
    Jynneos is a two-dose vaccine that is federally approved to prevent monkeypox and smallpox. ACAM2000 is an older generation, single-dose vaccine approved to prevent smallpox, but can also be used against monkeypox under a CDC program. However, ACAM2000 can have serious side effects.
    The CDC has told people with confirmed or suspected monkeypox infections to isolate at home until local or state health departments say otherwise. People with confirmed infections should remain in isolation until the skin lesions that characterize the disease have completely resolved, the scabs have fallen off and a new layer of skin has formed.
    Monkeypox typically starts with symptoms similar to the flu including fever, headache, muscle aches, chills, exhaustion and swollen lymph nodes. Lesions then form on the body, and the virus spreads primarily through skin-to-skin contact with these lesions. In eight cases in the U.S., the rash developed first on the genitals or the area round the anus. Monkeypox can spread through respiratory droplets if a person has lesions in their throat or mouth, but it does not transmit easily this way.
    “The rash caused by monkeypox virus can spread widely across the body or present in sensitive areas like the genitalia. It can be really painful and some patients have reported needing prescription pain medicines to manage that pain,” McQuiston said.
    People exposed to monkeypox should monitor for symptoms for 21 days, according to the CDC. They should check their temperature twice daily and monitor for chills, swollen lymph nodes and new skin rashes. If a fever or a rash develops, the person should self-isolate and contact the local health department immediately.
    This is breaking news. Please check back for updates.

    WATCH LIVEWATCH IN THE APP More

  • in

    6 exceptional retail winners that Jim Cramer says are a buy

    Monday – Friday, 6:00 – 7:00 PM ET

    CNBC’s Jim Cramer on Friday highlighted six retail winners with standout quarters that investors should be lining up to purchase.
    “As the market trends down here, every single one of these … is a buy,” the “Mad Money” host said.

    CNBC’s Jim Cramer on Friday highlighted six retail winners with standout quarters that investors should be lining up to purchase.
    “No one ever made a dime from panicking. If you dumped any of these retail winners in response to Walmart and Target, you made a very big mistake. And you know what, as the market trends down here, every single one of these … is a buy,” he said.

    The “Mad Money” host’s comments come on the tail end of a jam-packed earnings season that saw the country’s largest retailers struggle to turn out a strong quarter, as roaring inflation led many consumers to be more selective about their purchases.
    At the same time, Cramer pointed out that many retailers whose business models allow them to combat inflation or sell cheap products that are attractive to frugal customers reported strong results for their most recent quarters. 
    Supply chain issues, such as the currently tight supply of cars due to the semiconductor shortage, also helped pad some retailers’ numbers, he added.
    Here is Cramer’s list of winners:

    AutoZone
    Williams-Sonoma
    Dollar General
    Dollar Tree
    Macy’s
    Costco

    Cramer added that Best Buy and Dick’s Sporting Goods deserve honorable mentions for having impressive numbers that didn’t quite beat expectations.

    Disclosure: Cramer’s Charitable Trust owns shares of Costco and Walmart.
    Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
    Disclaimer

    Questions for Cramer?Call Cramer: 1-800-743-CNBC
    Want to take a deep dive into Cramer’s world? Hit him up!Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
    Questions, comments, suggestions for the “Mad Money” website? [email protected]

    WATCH LIVEWATCH IN THE APP More